ENTITY
Merck & Co

Merck & Co (MRK US)

211
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
bullishMerck & Co
22 Nov 2024 15:00

Merck & Co. Inc.: Expanding Oncology Portfolio through KEYTRUDA Developments & Partnership Collaborations To Shape the Future! - Major Drivers

Merck & Co. has demonstrated robust operational performance and strategic advances in its third quarter earnings, navigating through both...

Logo
375 Views
Share
bullishMerck & Co
31 Oct 2024 16:17Podcast

Merck & Co: Blockbuster Drugs - [Business Breakdowns, EP.189]

Business Breakdowns explores Merck, a leading pharmaceutical company known for innovation in oncology and future drug pipeline, navigating...

Logo
880 Views
Share
bullishMerck & Co
03 Sep 2024 16:00

Merck & Co.: Expanding Market for GARDASIL

Merck & Co.'s second quarter earnings call underscored both the progress and challenges faced by the company as it pushes forward in an...

Logo
190 Views
Share
bullishAlteogen Inc
05 Feb 2025 08:30

Alteogen (196170 KS): More ALT-B4 Licensing Deal to Follow; Fund Raise Wipes Off Uncertainty

​Alteogen secures $20M upfront payment in exclusive license deal with Daiichi Sankyo for using ALT-B4 in developing SC version of blockbuster ADC...

Logo
199 Views
Share
bullishMerck & Co
26 May 2024 03:00

Merck & Co.: Progress in Personalized Cancer Vaccine Collaborated with Moderna & Other Major Drivers

In the first quarter of 2024, Merck & Co. demonstrated a strong start with robust growth across its business. This was mainly led by the...

Logo
319 Views
Share
x